194 related articles for article (PubMed ID: 9486424)
1. Nonenzymatic glycation of cartilage proteoglycans: an in vivo and in vitro study.
Pokharna HK; Pottenger LA
Glycoconj J; 1997 Dec; 14(8):917-23. PubMed ID: 9486424
[TBL] [Abstract][Full Text] [Related]
2. Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover.
Verzijl N; DeGroot J; Bank RA; Bayliss MT; Bijlsma JW; Lafeber FP; Maroudas A; TeKoppele JM
Matrix Biol; 2001 Nov; 20(7):409-17. PubMed ID: 11691581
[TBL] [Abstract][Full Text] [Related]
3. Glycation induced crosslinking of link proteins, in vivo and in vitro.
Pokharna HK; Pottenger LA
J Surg Res; 2000 Nov; 94(1):35-42. PubMed ID: 11038300
[TBL] [Abstract][Full Text] [Related]
4. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation.
DeGroot J; Verzijl N; Bank RA; Lafeber FP; Bijlsma JW; TeKoppele JM
Arthritis Rheum; 1999 May; 42(5):1003-9. PubMed ID: 10323457
[TBL] [Abstract][Full Text] [Related]
5. Age-related accumulation of pentosidine in aggrecan and collagen from normal and degenerate human intervertebral discs.
Sivan SS; Tsitron E; Wachtel E; Roughley P; Sakkee N; van der Ham F; Degroot J; Maroudas A
Biochem J; 2006 Oct; 399(1):29-35. PubMed ID: 16787390
[TBL] [Abstract][Full Text] [Related]
6. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
[TBL] [Abstract][Full Text] [Related]
7. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
8. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
9. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products.
DeGroot J; Verzijl N; Wenting-Van Wijk MJ; Bank RA; Lafeber FP; Bijlsma JW; TeKoppele JM
Arthritis Rheum; 2001 Nov; 44(11):2562-71. PubMed ID: 11710713
[TBL] [Abstract][Full Text] [Related]
10. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis.
Verzijl N; DeGroot J; Ben ZC; Brau-Benjamin O; Maroudas A; Bank RA; Mizrahi J; Schalkwijk CG; Thorpe SR; Baynes JW; Bijlsma JW; Lafeber FP; TeKoppele JM
Arthritis Rheum; 2002 Jan; 46(1):114-23. PubMed ID: 11822407
[TBL] [Abstract][Full Text] [Related]
11. Cartilage chondrolysis by fibronectin fragments causes cleavage of aggrecan at the same site as found in osteoarthritic cartilage.
Homandberg GA; Davis G; Maniglia C; Shrikhande A
Osteoarthritis Cartilage; 1997 Nov; 5(6):450-3. PubMed ID: 9536293
[No Abstract] [Full Text] [Related]
12. Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage.
Poole AR; Rosenberg LC; Reiner A; Ionescu M; Bogoch E; Roughley PJ
J Orthop Res; 1996 Sep; 14(5):681-9. PubMed ID: 8893759
[TBL] [Abstract][Full Text] [Related]
13. The epidermal growth factor-like domain of the large proteoglycans from articular cartilage (aggrecans). Estimate of content at different ages and in osteoarthritis.
Stanescu V; Chaminade F; Stanescu R
Osteoarthritis Cartilage; 1993 Jul; 1(3):179-84. PubMed ID: 15449424
[TBL] [Abstract][Full Text] [Related]
14. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
[TBL] [Abstract][Full Text] [Related]
15. Proteoglycans isolated from dissociative extracts of differently aged human articular cartilage: characterization of naturally occurring hyaluronan-binding fragments of aggrecan.
Vilim V; Fosang AJ
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):887-94. PubMed ID: 7818495
[TBL] [Abstract][Full Text] [Related]
16. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
Sandy JD; Verscharen C
Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
[TBL] [Abstract][Full Text] [Related]
17. Effect of link protein concentration on articular cartilage proteoglycan aggregation.
Tang LH; Buckwalter JA; Rosenberg LC
J Orthop Res; 1996 Mar; 14(2):334-9. PubMed ID: 8648515
[TBL] [Abstract][Full Text] [Related]
18. Lysyl oxidase and Maillard reaction-mediated crosslinks in aging and osteoarthritic rabbit cartilage.
Pokharna HK; Monnier V; Boja B; Moskowitz RW
J Orthop Res; 1995 Jan; 13(1):13-21. PubMed ID: 7853094
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes in the content of the C-terminal region of aggrecan in human articular cartilage.
Dudhia J; Davidson CM; Wells TM; Vynios DH; Hardingham TE; Bayliss MT
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):933-40. PubMed ID: 8611178
[TBL] [Abstract][Full Text] [Related]
20. Aggrecan in bovine tendon.
Vogel KG; Sandy JD; Pogány G; Robbins JR
Matrix Biol; 1994 Mar; 14(2):171-9. PubMed ID: 7520336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
